UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Clinical cancer research, 2001-08, Vol.7 (8), p.2182-2194

2001

Volltextzugriff (PDF)

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

British journal of cancer, 2003-04, Vol.88 (8), p.1199-1206

2003

Volltextzugriff (PDF)

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

British journal of cancer, 1997-10, Vol.76 (8), p.1055-1061

1997

Volltextzugriff (PDF)

Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

British journal of cancer, 2001-10, Vol.85 (8), p.1099-1101

2001

Volltextzugriff (PDF)

Thalidomide in solid tumours: the resurrection of an old drug

European journal of cancer (1990), 2004-11, Vol.40 (16), p.2377-2382

2004

Volltextzugriff (PDF)

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

European journal of cancer (1990), 2003, Vol.39 (1), p.70-77

2003

Volltextzugriff (PDF)

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1837-1843

1997

Volltextzugriff (PDF)

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

JNCI : Journal of the National Cancer Institute, 1997-10, Vol.89 (19), p.1429-1439

1997

Volltextzugriff (PDF)

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

British journal of cancer, 2002-01, Vol.86 (1), p.19-25

2002

Volltextzugriff (PDF)

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3733-3739

2001

Volltextzugriff (PDF)

Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Pathology, research and practice, 1996, Vol.192 (7), p.768-780

1996

Volltextzugriff (PDF)

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens

European journal of cancer (1990), 2003-04, Vol.39 (6), p.793-799

2003

Volltextzugriff (PDF)

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

British journal of cancer, 2003-12, Vol.89 (11), p.2045-2050

2003

Volltextzugriff (PDF)

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.309-318

2001

Volltextzugriff (PDF)

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

British journal of cancer, 1998-11, Vol.78 (10), p.1342-1345

1998

Volltextzugriff (PDF)

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

British journal of cancer, 1997-01, Vol.76 (7), p.952-962

1997

Volltextzugriff (PDF)

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial

European journal of cancer (1990), 2004-02, Vol.40 (3), p.352-357

2004

Volltextzugriff (PDF)

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

British journal of cancer, 2002-03, Vol.86 (5), p.669-673

2002

Volltextzugriff (PDF)

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

British journal of cancer, 1998-09, Vol.78 (6), p.828-832

1998

Volltextzugriff (PDF)

Irinotecan (CPT-11) metabolism and disposition in cancer patients

Clinical cancer research, 1998-11, Vol.4 (11), p.2747-2754

1998

Volltextzugriff (PDF)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

British journal of cancer, 2001-11, Vol.85 (9), p.1359-1367

2001

Volltextzugriff (PDF)

The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer

British journal of cancer, 1997-01, Vol.76 (4), p.486-493

1997

Volltextzugriff (PDF)

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

Journal of clinical oncology, 1996-02, Vol.14 (2), p.619-627

1996

Volltextzugriff (PDF)

Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction : Implications for loss of transgene expression

Human gene therapy, 2005-12, Vol.16 (12), p.1452-1462

2005

Volltextzugriff (PDF)

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1177-1187

1995

Volltextzugriff (PDF)

1 – 25 von 455

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(353)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(290)
Science & Technology
(265)
Life Sciences & Biomedicine
(238)
Biological And Medical Sciences
(183)
Medical Sciences
(180)
Oncology
(168)
Male
(163)
Female
(157)
Middle Aged
(155)
Pharmacology. Drug Treatments
(153)
Adult
(137)
Aged
(129)
Antineoplastic Agents
(127)
Chemotherapy
(92)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(70)
Cisplatin - Administration & Dosage
(60)
Prognosis
(41)
Immunotherapy
(40)
Drug Administration Schedule
(39)
Physical Sciences
(37)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

Thalidomide in solid tumours: the resurrection of an old drug

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

Irinotecan (CPT-11) metabolism and disposition in cancer patients

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia

Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction : Implications for loss of transgene expression

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups

Suchergebnisse filtern